All News

A cancer survivor explains how she is approaching her reentry into the world after COVID-19 restrictions have been lifted.

Recent findings showed that the cost of cancer care affects nearly half of women with gynecologic cancer, with younger and/or non-white patients at higher risk for financial toxicity.

The upcoming symposium will give members of the colorectal cancer community a chance to spread awareness and discuss prevention and treatment strategies for the disease in younger age groups.

Results from a recent study strongly support a treatment regimen of Darzalex with Revlimid and dexamethasone as a new standard of care for patients with transplant-ineligible newly diagnosed multiple myeloma.

Patients with metastatic KRAS G12C mutated non-small cell lung cancer now have another treatment option if they previously failed at least one line of therapy.

A mother describes how her daughter discovered a lump that led to a breast cancer diagnosis.

From the rapid vaccine development to heart risks and delaying immunization, we spoke with an infectious disease expert on common worries people have about getting the COVID-19 vaccine.

The findings open up the door for a fourth-line treatment option in patients with advanced gastrointestinal stromal tumors with disease progression.

On behalf of the Head and Neck Cancer Alliance, Dr. Michael Moore spoke with CURE® about emerging therapies that potentially offer exciting new options for the future.

“Each person living with cancer has a story to tell, but some may choose not to share it because of its personal nature,” writes one survivor. In this piece, she describes how she found a way to give her story words.

The disease, which advanced to his spine and bones, prevented him from appearing onstage for the “Friends” reunion.

From public health professional to a patient with breast cancer, this person details the selfless that an oncology nurse exhibits in her daily life.

A man with breast cancer recalls his introduction to cancer as a child.

As a hard-working mom and administrator, one nurse shows her passion and fight to get the best care for patients with fibrolamellar carcinoma.

A woman with metastatic breast cancer expresses her concerns about COVID-19 restrictions being lifted and shares an idea for those who are immunocompromised to indicate their health status.

An oncologist describes how gifted and compassionate her primary nurse is with the clinical team and with patients with genitourinary and gynecologic cancers.

A patient with metastatic breast cancer credits her oncology nurse’s compassion for giving her the strength to persevere during her cancer journey.

Patients taking checkpoint inhibitors or immunotherapy in combination with other treatments need to be aware of this potential side effect and the associated symptoms.

A pancreatic cancer survivor explains what your priorities in life should truly be.

From a man with late-stage cancer who has matching tattoos with over 400 strangers to a 78-year-old cancer survivor getting his black belt in Taekwondo, here’s what’s happening in the cancer landscape this week.

One expert tells patients to ‘hang tight’ as immunotherapy options are getting better each year.

Some patients with MPN in the UK were not prescribed the correct medications for management of specific diseases, highlighting the need for improvements in cardiovascular and thrombotic risk management.

Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.

A woman with stage 4 ovarian cancer discusses the importance of having compassion for other people, because you never know what they may be dealing with.

In this episode of the “CURE® Talks Cancer” podcast, Colin Jackson explains how he was able to complete a marathon even after cancer treatments that called for surgical removal of part of his femur, hip and surrounding muscle.

Novel combo regimen reduces number of toxic treatments in patients with NSCLC.

The combination of Imbruvica with Venclexta significantly reduced the risk for progression or death by 78% compared with chlorambucil plus obinutuzumab.

In an interview with CURE®, a survivor recounts how his experiences with cancer treatment in the 1960s, when he was treated in a segregated “colored” ward, have led him to a life of advocacy work.